Skip to main content

Table 10 Recommendation summary - other subjects

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

other subjects   CEBAM ACP HAS KDIGO KHA-CARI BCMA UMHS VA-DoD NICE
2012 2013 2013 2013 2013 2014 2014 2014 2015
patient education       
diet protein intake (in g/kg/day)     0.8 0.75–1.0    0.6–0.8  
  no low protein diet < 0.6 g/kg/day        
complications CKD-mineral bone disorder     
diabetes HbA1c target values (in %)     7.0     < 7.0  
  metformin with caution      avoid/reduce    
  cardiovascular risk         
hyperlipidemia         
  statins for cardiovascular risk     i    i   
  statins for CKD progression         
  ezetimibe        i   
congestive heart failure         
antigoagulants and antiplatelets      
nephrotoxic Medication geneneral        
  NSAID         
vaccinations          
metabolism hyperuricemia        
  oral bicarbonate       
nephrotoxic medication        
  1. ▪ recommendation, − negative recommendation, i: when indicated, ➢ referral to KDIGO and NICE guidelines on lipid management, CKD chronic kidney disease, HbA1c glycated Hemoglobin, NSAID nonsteroidal anti-inflammatory drugs
  2. American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasiansians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)